Global Hepatitis A Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112260365 | Category: Pharma & Healthcare | Pages: 103 | Format: PDF | Published Date: November 14,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Hepatitis A Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hepatitis A Vaccine market size is estimated to be worth US$ 813.9 million in 2021 and is forecast to a readjusted size of USD 935.5 million by 2028 with a CAGR of 2.0% during review period. Government Institution accounting for % of the Hepatitis A Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Inactivated Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Hepatitis A Vaccine include GSK, Merck, Sanofi, Sinovac, and Zhejiang Pukang, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hepatitis A Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Inactivated Vaccine
    Live Attenuated Vaccine
Market segment by Application can be divided into
    Government Institution
    Private Sector
    Other
The key market players for global Hepatitis A Vaccine market are listed below:
    GSK
    Merck
    Sanofi
    Sinovac
    Zhejiang Pukang
    Changchun Institute of Biological
    KM Biologics
    IMBCA
    ChangSheng
    Convac
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatitis A Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepatitis A Vaccine, with price, sales, revenue and global market share of Hepatitis A Vaccine from 2019 to 2022.
Chapter 3, the Hepatitis A Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis A Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hepatitis A Vaccine.
Chapter 13, 14, and 15, to describe Hepatitis A Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Hepatitis A Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Hepatitis A Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Inactivated Vaccine
        1.2.3 Live Attenuated Vaccine
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Hepatitis A Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Government Institution
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Global Hepatitis A Vaccine Market Size & Forecast
        1.4.1 Global Hepatitis A Vaccine Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Hepatitis A Vaccine Sales in Volume (2017-2028)
        1.4.3 Global Hepatitis A Vaccine Price (2017-2028) 
    1.5 Global Hepatitis A Vaccine Production Capacity Analysis
        1.5.1 Global Hepatitis A Vaccine Total Production Capacity (2017-2028)
        1.5.2 Global Hepatitis A Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Hepatitis A Vaccine Market Drivers
        1.6.2 Hepatitis A Vaccine Market Restraints
        1.6.3 Hepatitis A Vaccine Trends Analysis
2 Manufacturers Profiles
    2.1 GSK
        2.1.1 GSK Details
        2.1.2 GSK Major Business
        2.1.3 GSK Hepatitis A Vaccine Product and Services
        2.1.4 GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Hepatitis A Vaccine Product and Services
        2.2.4 Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Sanofi
        2.3.1 Sanofi Details
        2.3.2 Sanofi Major Business
        2.3.3 Sanofi Hepatitis A Vaccine Product and Services
        2.3.4 Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Sinovac
        2.4.1 Sinovac Details
        2.4.2 Sinovac Major Business
        2.4.3 Sinovac Hepatitis A Vaccine Product and Services
        2.4.4 Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Zhejiang Pukang
        2.5.1 Zhejiang Pukang Details
        2.5.2 Zhejiang Pukang Major Business
        2.5.3 Zhejiang Pukang Hepatitis A Vaccine Product and Services
        2.5.4 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Changchun Institute of Biological
        2.6.1 Changchun Institute of Biological Details
        2.6.2 Changchun Institute of Biological Major Business
        2.6.3 Changchun Institute of Biological Hepatitis A Vaccine Product and Services
        2.6.4 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 KM Biologics
        2.7.1 KM Biologics Details
        2.7.2 KM Biologics Major Business
        2.7.3 KM Biologics Hepatitis A Vaccine Product and Services
        2.7.4 KM Biologics Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 IMBCA
        2.8.1 IMBCA Details
        2.8.2 IMBCA Major Business
        2.8.3 IMBCA Hepatitis A Vaccine Product and Services
        2.8.4 IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 ChangSheng
        2.9.1 ChangSheng Details
        2.9.2 ChangSheng Major Business
        2.9.3 ChangSheng Hepatitis A Vaccine Product and Services
        2.9.4 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Convac
        2.10.1 Convac Details
        2.10.2 Convac Major Business
        2.10.3 Convac Hepatitis A Vaccine Product and Services
        2.10.4 Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Hepatitis A Vaccine Breakdown Data by Manufacturer
    3.1 Global Hepatitis A Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Hepatitis A Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Hepatitis A Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Hepatitis A Vaccine Manufacturer Market Share in 2021
        3.4.2 Top 6 Hepatitis A Vaccine Manufacturer Market Share in 2021
    3.5 Global Hepatitis A Vaccine Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Hepatitis A Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Hepatitis A Vaccine Market Size by Region
        4.1.1 Global Hepatitis A Vaccine Sales in Volume by Region (2017-2028)
        4.1.2 Global Hepatitis A Vaccine Revenue by Region (2017-2028)
    4.2 North America Hepatitis A Vaccine Revenue (2017-2028)
    4.3 Europe Hepatitis A Vaccine Revenue (2017-2028)
    4.4 Asia-Pacific Hepatitis A Vaccine Revenue (2017-2028)
    4.5 South America Hepatitis A Vaccine Revenue (2017-2028)
    4.6 Middle East and Africa Hepatitis A Vaccine Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Hepatitis A Vaccine Sales in Volume by Type (2017-2028)
    5.2 Global Hepatitis A Vaccine Revenue by Type (2017-2028)
    5.3 Global Hepatitis A Vaccine Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Hepatitis A Vaccine Sales in Volume by Application (2017-2028)
    6.2 Global Hepatitis A Vaccine Revenue by Application (2017-2028)
    6.3 Global Hepatitis A Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Hepatitis A Vaccine Sales by Type (2017-2028)
    7.2 North America Hepatitis A Vaccine Sales by Application (2017-2028)
    7.3 North America Hepatitis A Vaccine Market Size by Country
        7.3.1 North America Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
        7.3.2 North America Hepatitis A Vaccine Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Hepatitis A Vaccine Sales by Type (2017-2028)
    8.2 Europe Hepatitis A Vaccine Sales by Application (2017-2028)
    8.3 Europe Hepatitis A Vaccine Market Size by Country
        8.3.1 Europe Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
        8.3.2 Europe Hepatitis A Vaccine Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Hepatitis A Vaccine Sales by Type (2017-2028)
    9.2 Asia-Pacific Hepatitis A Vaccine Sales by Application (2017-2028)
    9.3 Asia-Pacific Hepatitis A Vaccine Market Size by Region
        9.3.1 Asia-Pacific Hepatitis A Vaccine Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Hepatitis A Vaccine Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Hepatitis A Vaccine Sales by Type (2017-2028)
    10.2 South America Hepatitis A Vaccine Sales by Application (2017-2028)
    10.3 South America Hepatitis A Vaccine Market Size by Country
        10.3.1 South America Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
        10.3.2 South America Hepatitis A Vaccine Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Hepatitis A Vaccine Sales by Type (2017-2028)
    11.2 Middle East & Africa Hepatitis A Vaccine Sales by Application (2017-2028)
    11.3 Middle East & Africa Hepatitis A Vaccine Market Size by Country
        11.3.1 Middle East & Africa Hepatitis A Vaccine Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Hepatitis A Vaccine Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Hepatitis A Vaccine and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Hepatitis A Vaccine
    12.3 Hepatitis A Vaccine Production Process
    12.4 Hepatitis A Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Hepatitis A Vaccine Typical Distributors
    13.3 Hepatitis A Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Hepatitis A Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?